WO2008054788A3 - Transdermal delivery techniques for drugs, nutraceuticals and other active substances - Google Patents

Transdermal delivery techniques for drugs, nutraceuticals and other active substances Download PDF

Info

Publication number
WO2008054788A3
WO2008054788A3 PCT/US2007/023006 US2007023006W WO2008054788A3 WO 2008054788 A3 WO2008054788 A3 WO 2008054788A3 US 2007023006 W US2007023006 W US 2007023006W WO 2008054788 A3 WO2008054788 A3 WO 2008054788A3
Authority
WO
WIPO (PCT)
Prior art keywords
nutraceuticals
disease
drugs
stimulants
medications
Prior art date
Application number
PCT/US2007/023006
Other languages
French (fr)
Other versions
WO2008054788A9 (en
WO2008054788A2 (en
Inventor
Guy Dipierro
Steven A Giannos
Original Assignee
Chrono Therapeutics Inc
Guy Dipierro
Steven A Giannos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chrono Therapeutics Inc, Guy Dipierro, Steven A Giannos filed Critical Chrono Therapeutics Inc
Priority to CA002668184A priority Critical patent/CA2668184A1/en
Publication of WO2008054788A2 publication Critical patent/WO2008054788A2/en
Publication of WO2008054788A9 publication Critical patent/WO2008054788A9/en
Publication of WO2008054788A3 publication Critical patent/WO2008054788A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Systems and methods for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and treating hyperglycemia, Alzheimer's disease, sleep disorders, Parkinson's disease, Attention Deficit Disorder and nicotine addiction involve synchronizing and tailoring the administration of nutraceuticals, medications and other substances (for example, stimulants) in accordance with the body's natural circadian rhythms, meal times and other factors. Improved control of blood glucose levels, extended alertness, and weight control, and counteracting of disease symptoms when they are at their worst are possible. An automated, pre-programmable transdermal administration system is used to provide pulsed doses of medications, pharmaceuticals, hormones, neuropeptides, anorexigens, pro-drugs, stimulants, plant extracts, botanicals, nutraceuticals, cosmeceuticals, phytochemicals, phytonutrients, enzymes, antioxidants, essential oils, fatty acids, minerals, vitamins, amino acids, coenzymes, or other physiological active ingredient or precursor. The system can utilize a pump, pressurized reservoir, a system for removing depleted carrier solution, or other modulated dispensing actuator, in conjunction with porous membranes or micro-fabricated structures.
PCT/US2007/023006 2006-10-31 2007-10-31 Transdermal delivery techniques for drugs, nutraceuticals and other active substances WO2008054788A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002668184A CA2668184A1 (en) 2006-10-31 2007-10-31 Transdermal delivery techniques for drugs, nutraceuticals and other active substances

Applications Claiming Priority (20)

Application Number Priority Date Filing Date Title
US86365406P 2006-10-31 2006-10-31
US86360806P 2006-10-31 2006-10-31
US86364006P 2006-10-31 2006-10-31
US86360706P 2006-10-31 2006-10-31
US86367106P 2006-10-31 2006-10-31
US86366606P 2006-10-31 2006-10-31
US86368606P 2006-10-31 2006-10-31
US86367706P 2006-10-31 2006-10-31
US86361806P 2006-10-31 2006-10-31
US86361306P 2006-10-31 2006-10-31
US60/863,607 2006-10-31
US60/863,618 2006-10-31
US60/863,677 2006-10-31
US60/863,666 2006-10-31
US60/863,613 2006-10-31
US60/863,671 2006-10-31
US60/863,608 2006-10-31
US60/863,640 2006-10-31
US60/863,686 2006-10-31
US60/863,654 2006-10-31

Publications (3)

Publication Number Publication Date
WO2008054788A2 WO2008054788A2 (en) 2008-05-08
WO2008054788A9 WO2008054788A9 (en) 2008-07-10
WO2008054788A3 true WO2008054788A3 (en) 2008-11-13

Family

ID=39344904

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/023006 WO2008054788A2 (en) 2006-10-31 2007-10-31 Transdermal delivery techniques for drugs, nutraceuticals and other active substances

Country Status (2)

Country Link
CA (1) CA2668184A1 (en)
WO (1) WO2008054788A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252321B2 (en) * 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
EP1998829B1 (en) 2006-03-14 2011-02-09 University Of Southern California Mems device for delivery of therapeutic agents
US9308124B2 (en) 2007-12-20 2016-04-12 University Of Southern California Apparatus and methods for delivering therapeutic agents
ES2603027T3 (en) 2008-05-08 2017-02-23 Minipumps, Llc Methods of manufacturing drug delivery pumps
DK2320989T3 (en) 2008-05-08 2015-06-22 Minipumps Llc IMPLANT PUMPS AND CANNELS THEREOF
US9849238B2 (en) 2008-05-08 2017-12-26 Minipumps, Llc Drug-delivery pump with intelligent control
EP2419085A4 (en) * 2009-04-14 2013-04-24 Univ California ENHANCED MEDICAL DEVICES FOR ORAL USE AND MEDICAMENT FORMULATIONS
WO2011022484A1 (en) 2009-08-18 2011-02-24 Replenish Pumps. Llc Electrolytic drug-delivery pump with adaptive control
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
EP3226972A4 (en) * 2014-12-01 2018-08-08 Achelios Therapeutics, Inc. Methods and compositions for treating migraine and conditions associated with pain
JP2018511355A (en) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． Drug delivery method and system
CA2977814A1 (en) 2015-03-12 2016-09-15 Chrono Therapeutics Inc. Craving input and support system
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
WO2019232077A1 (en) 2018-05-29 2019-12-05 Chrono Therapeutics Inc. Drug delivery methods and systems
TR201808384A2 (en) * 2018-06-12 2018-07-23 Yahya Yagiz Kemikoglu PHARMACEUTICAL CARRIER HOURS
CU20200106A7 (en) * 2018-06-20 2021-08-06 Axcella Health Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASEMIAS
US10881622B2 (en) 2018-09-17 2021-01-05 Xinova, LLC Smart transdermal microdispensing system for integrated weight management
CN113425602B (en) * 2021-06-29 2023-05-23 四川省肿瘤医院 Tablet tube feeding method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917676A (en) * 1986-11-20 1990-04-17 Ciba-Geigy Corporation User-activated transdermal therapeutic system
US5013293A (en) * 1987-05-28 1991-05-07 Drug Delivery Systems Inc. Pulsating transdermal drug delivery system
US5415629A (en) * 1993-09-15 1995-05-16 Henley; Julian L. Programmable apparatus for the transdermal delivery of drugs and method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917676A (en) * 1986-11-20 1990-04-17 Ciba-Geigy Corporation User-activated transdermal therapeutic system
US5013293A (en) * 1987-05-28 1991-05-07 Drug Delivery Systems Inc. Pulsating transdermal drug delivery system
US5415629A (en) * 1993-09-15 1995-05-16 Henley; Julian L. Programmable apparatus for the transdermal delivery of drugs and method

Also Published As

Publication number Publication date
WO2008054788A9 (en) 2008-07-10
CA2668184A1 (en) 2008-05-08
WO2008054788A2 (en) 2008-05-08

Similar Documents

Publication Publication Date Title
WO2008054788A3 (en) Transdermal delivery techniques for drugs, nutraceuticals and other active substances
US11471424B2 (en) Biosynchronous transdermal drug delivery
US8628517B2 (en) Micro-fluidic device for drug delivery
JP5486211B2 (en) Transdermal administration device and needle forming body used in the device
US20200121769A1 (en) Direct application system and method for the delivery of bioactive compositions and formulations
CN104870049B (en) Adhesive assembly and the micropin injection device including the adhesive assembly
US10980865B2 (en) Direct application system and method for the delivery of bioactive compositions and formulations
JP7420797B2 (en) Drug delivery methods and systems
JP5476062B2 (en) Transdermal device
US8328757B2 (en) Bladder arrangement for microneedle-based drug delivery device
CN105916543B (en) Microneedle unit and microneedle assembly
US20140207047A1 (en) Transdermal drug delivery system and method
JP5558047B2 (en) Substance supply device
EP2547396B1 (en) A built-in non-verbal instructional device integratable to applicators
WO2007108988A3 (en) Infusion device with pressurizable liquid medicament chamber
JP4540688B2 (en) Fastening means for a wearable pharmaceutical injector used by being fastened to a living body
US20050240154A1 (en) Infusion set with patch
EP3607992B1 (en) Applicator for water-soluble sheet-shaped preparation
JP2018511355A (en) Drug delivery method and system
WO2000074763A3 (en) Devices and methods for enhanced microneedle penetration of biological barriers
TW200613029A (en) System and method for drug delivery and microfluidic applications using microneedles
KR20190114815A (en) Multi type micro-needle
Sawon et al. Design and optimization of a microneedle with skin insertion analysis for transdermal drug delivery applications
JP2015116335A (en) Percutaneous drug delivery system and method of manufacturing percutaneous drug delivery system
Jiawook Manufacturing nanoimprint lithography system to produce efficient microneedles patch for transdermal drug delivery

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07867327

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2668184

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07867327

Country of ref document: EP

Kind code of ref document: A2